Zenith Drugs wins ₹75 Lakhs export order from Mauritius

1 min read     Updated on 03 Jun 2026, 08:55 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Zenith Drugs Limited secured a ₹75 Lakhs export order from the Ministry of Health and Wellness, Government of Mauritius, for pharmaceutical products on June 02, 2026. The order strengthens the company's international portfolio and reinforces its presence in overseas markets.

powered bylight_fuzz_icon
42002694

*this image is generated using AI for illustrative purposes only.

Zenith Drugs Limited has secured an export order worth approximately ₹75 Lakhs from the Ministry of Health and Wellness, Government of Mauritius, for the supply of pharmaceutical products. The order, disclosed on June 02, 2026, underscores the trust placed in the company's manufacturing capabilities and quality standards. This development is significant as it bolsters Zenith Drugs Limited's international business portfolio and reinforces its presence in overseas markets.

Order Details

The export order was received under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company stated that this order reflects continued confidence in its products and manufacturing standards. Zenith Drugs Limited remains committed to delivering high-quality pharmaceutical products in accordance with the specified requirements and timelines.

Strategic Implications

The receipt of this order is part of the company's broader strategy to expand its global footprint. By securing contracts with government entities such as the Ministry of Health and Wellness, Government of Mauritius, the company aims to enhance its market reach while maintaining high standards of quality, compliance, and customer satisfaction.

Parameter Details
Order Value ₹75 Lakhs
Client Ministry of Health and Wellness, Government of Mauritius
Purpose Supply of pharmaceutical products
Disclosure Date June 02, 2026

The company continues to focus on expanding its operations in international markets, leveraging its manufacturing capabilities to meet global demand.

Historical Stock Returns for Zenith Drugs

1 Day5 Days1 Month6 Months1 Year5 Years
-2.64%-10.67%+2.40%-25.64%-40.25%-61.39%

How will this order impact Zenith Drugs' revenue growth in the upcoming fiscal year?

Does this contract signal potential for future collaborations with other government entities in the region?

What steps is the company taking to expand its manufacturing capacity to meet rising international demand?

Zenith Drugs secures export orders worth ₹2.50 Crores

0 min read     Updated on 29 May 2026, 12:24 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Zenith Drugs Limited has registered its manufacturing plant and products in Afghanistan, securing first export orders worth ₹2.50 Crores as disclosed in a May 28, 2026 filing.

powered bylight_fuzz_icon
41583255

*this image is generated using AI for illustrative purposes only.

Zenith Drugs Limited has expanded its international footprint by registering its manufacturing plant and products in Afghanistan, resulting in the receipt of its first export orders worth ₹2.50 Crores. This strategic move allows the pharmaceutical company to penetrate the Afghan market, leveraging its newly registered manufacturing capabilities to meet overseas demand.

The company submitted the details regarding this commercial development to the stock exchanges under Regulation 30. The filing confirms the successful completion of necessary registration procedures for both the facility and the specific product lines intended for export.

Export Order Details

The initial order book from Afghanistan stands at ₹2.50 Crores. This represents the immediate financial impact of the company's market entry strategy following the regulatory approvals obtained in the region.

Parameter Details
Market Afghanistan
Order Value ₹2.50 Crores
Milestone First export orders

Historical Stock Returns for Zenith Drugs

1 Day5 Days1 Month6 Months1 Year5 Years
-2.64%-10.67%+2.40%-25.64%-40.25%-61.39%

What is the projected timeline for receiving subsequent export orders from the Afghan market?

Does Zenith Drugs plan to leverage this regulatory approval to expand into other neighboring Central Asian markets?

How will the company manage the logistical and currency risks associated with exporting to Afghanistan?

More News on Zenith Drugs

1 Year Returns:-40.25%